Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.280
-0.010 (-0.78%)
At close: Mar 9, 2026, 4:00 PM EDT
1.250
-0.030 (-2.34%)
After-hours: Mar 9, 2026, 6:29 PM EDT

Revelation Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Cash & Equivalents
10.76.511.995.251.27
Upgrade
Short-Term Investments
0.06----
Upgrade
Cash & Short-Term Investments
10.766.511.995.251.27
Upgrade
Cash Growth
65.54%-45.80%128.28%312.09%-71.63%
Upgrade
Prepaid Expenses
0.050.070.080.070.64
Upgrade
Other Current Assets
--0.070.09-
Upgrade
Total Current Assets
10.816.5712.155.411.91
Upgrade
Property, Plant & Equipment
0.740.060.070.090.13
Upgrade
Other Long-Term Assets
0.03----
Upgrade
Total Assets
11.586.6212.215.52.04
Upgrade
Accounts Payable
0.580.781.360.550.6
Upgrade
Accrued Expenses
1.41.131.150.991.53
Upgrade
Current Portion of Leases
0.02---0.02
Upgrade
Other Current Liabilities
--3.052.91-
Upgrade
Total Current Liabilities
21.915.564.452.14
Upgrade
Long-Term Leases
0.72----
Upgrade
Total Liabilities
2.721.915.564.452.14
Upgrade
Common Stock
00000
Upgrade
Additional Paid-In Capital
58.2845.2132.1126.414.42
Upgrade
Retained Earnings
-49.42-40.51-25.47-25.35-14.52
Upgrade
Total Common Equity
8.864.716.651.05-0.1
Upgrade
Shareholders' Equity
8.864.716.651.05-0.1
Upgrade
Total Liabilities & Equity
11.586.6212.215.52.04
Upgrade
Total Debt
0.75---0.02
Upgrade
Net Cash (Debt)
10.016.511.995.251.26
Upgrade
Net Cash Growth
54.05%-45.80%128.28%317.57%-72.00%
Upgrade
Net Cash Per Share
16.13454.70---
Upgrade
Filing Date Shares Outstanding
3.720.08---
Upgrade
Total Common Shares Outstanding
1.580.04---
Upgrade
Working Capital
8.814.656.580.96-0.23
Upgrade
Book Value Per Share
5.59108.19---
Upgrade
Tangible Book Value
8.864.716.651.05-0.1
Upgrade
Tangible Book Value Per Share
5.59108.19---
Upgrade
Machinery
0.120.150.130.130.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.